News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hoelscher Paul W.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Hoelscher Paul W. (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 06/03/2022 |
4
| Hoelscher Paul W. (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 6,376 options to buy
@ $2.09, valued at
$13.3k
|
|
| 04/22/2022 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 28,458 shares
@ $114.36, valued at
$3.3M
Sold 21,542 shares
@ $115.17, valued at
$2.5M
Exercised 50,000 options to buy
@ $22.14, valued at
$1.1M
|
|
| 04/08/2022 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 215,335 shares
@ $110.009, valued at
$23.7M
Sold 91,710 shares
@ $110.0101, valued at
$10.1M
Exercised 30,275 options to buy
@ $15.96, valued at
$483.2k
Exercised 185,060 options to buy
@ $22.14, valued at
$4.1M
|
|
| 03/25/2022 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Gifted 66,626 shares
@ $0
Gifted 66,626 shares
@ $0
Gifted 172,226 shares
@ $0
Gifted 172,226 shares
@ $0
Sold 26,090 shares
@ $110.0039, valued at
$2.9M
Sold 11,699 shares
@ $110.0109, valued at
$1.3M
Sold 1,481 shares
@ $110, valued at
$162.9k
Sold 663 shares
@ $110, valued at
$72.9k
Exercised 26,090 options to buy
@ $15.96, valued at
$416.4k
|
|
| 01/24/2022 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Paid exercise price by delivering 2,463 shares
@ $86.42, valued at
$212.9k
Exercised 5,558 options to buy
@ $0 |
|
| 01/24/2022 |
4
| Hoelscher Paul W. (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options to buy
@ $8.01, valued at
$280.4k
|
|
| 01/24/2022 |
3
| Hoelscher Paul W. (Director) has filed a Form 3 on Reneo Pharmaceuticals, Inc. |
| 01/06/2022 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Granted 47,375 shares
@ $0
Paid exercise price by delivering 50,666 shares
@ $101.84, valued at
$5.2M
Granted 9,522 restricted stock units
@ $0
Exercised 17,983 restricted stock units
@ $0
Exercised 14,514 restricted stock units
@ $0
Exercised 11,067 restricted stock units
@ $0
Exercised 11,616 restricted stock units
@ $0
Exercised 11,642 restricted stock units
@ $0 |
|
| 12/30/2021 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Gifted 6,163 shares
@ $0
Gifted 6,163 shares
@ $0
Gifted 1,049 shares
@ $0
Sold 8,575 shares
@ $110, valued at
$943.3k
Exercised 8,575 options to buy
@ $15.96, valued at
$136.9k
|
|
| 07/30/2021 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Granted 8,708 shares
@ $0
Paid exercise price by delivering 3,858 shares
@ $102.5, valued at
$395.4k
Granted 17,418 options to buy
@ $0 |
|
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2020 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 27,753 shares
@ $75.73, valued at
$2.1M
Sold 1,823 shares
@ $76.23, valued at
$139k
|
|
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2020 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Granted 5,555 shares
@ $0
Paid exercise price by delivering 2,461 shares
@ $38.25, valued at
$94.1k
Granted 11,114 options to buy
@ $0 |
|
| 01/07/2020 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Granted 72,376 shares
@ $0
Paid exercise price by delivering 69,321 shares
@ $36.1, valued at
$2.5M
Granted 43,541 restricted stock units
@ $0
Exercised 17,982 restricted stock units
@ $0
Exercised 65,696 restricted stock units
@ $0 |
|
| 10/17/2019 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 10,000 shares
@ $28.01, valued at
$280.1k
Sold 10,000 shares
@ $28, valued at
$280k
|
|
| 09/04/2019 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 1,359 shares
@ $28, valued at
$38.1k
|
|
| 08/23/2019 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 56,702 shares
@ $28, valued at
$1.6M
Sold 14,201 shares
@ $28.01, valued at
$397.8k
Exercised 25,060 options to buy
@ $15.96, valued at
$400k
Exercised 4,516 options to buy
@ $22.14, valued at
$100k
|
|
| 03/25/2019 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Paid exercise price by delivering 13,733 shares
@ $26.84, valued at
$368.6k
Exercised 31,000 restricted stock units
@ $0 |
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2019 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Paid exercise price by delivering 29,419 shares
@ $20.39, valued at
$599.9k
Granted 53,948 restricted stock units
@ $0
Exercised 65,695 restricted stock units
@ $0 |
|
| 06/25/2018 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Paid exercise price by delivering 8,860 shares
@ $17.67, valued at
$156.6k
Exercised 20,000 restricted stock units
@ $0 |
|
| 05/07/2018 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Granted 197,087 restricted stock units
@ $0 |
|
| 03/27/2018 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Paid exercise price by delivering 13,733 shares
@ $13.86, valued at
$190.3k
Exercised 31,000 restricted stock units
@ $0 |
|
| 06/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/27/2016 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Paid exercise price by delivering 8,643 shares
@ $17.44, valued at
$150.7k
Exercised 20,000 restricted stock units
@ $0 |
|
| 03/24/2016 |
4
| Hoelscher Paul W. (EVP, CFO) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Paid exercise price by delivering 9,641 shares
@ $16.32, valued at
$157.3k
Exercised 31,000 restricted stock units
@ $0 |
|
|
|